Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1/2 4Phase 3 3Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 10Completed 7Active not recruiting 7Not yet recruiting 4Unknown 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

Bevacizumab 14Injections 13Drug Therapy 10Gemcitabine 9toripalimab 8venetoclax 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Cyclophosphamide 7Carboplatin 7pembrolizumab 6irinotecan sucrosofate 6Temozolomide 6HMPL-013 6tislelizumab 5sintilimab 5fludarabine 5N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5Fluorouracil 5Etoposide 5Cisplatin 5Biopsy 5osimertinib 4lenvatinib 4Rituximab 4Radiotherapy 4Pemetrexed 4Paclitaxel 4Oxaliplatin 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × osimertinib × Clear all
NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1/2 Not yet recruiting
282 enrolled
Other solid neoplasm

Solid Tumor

NCT07486648 2026-03-24

Precision

Shanxi Province Cancer Hospital

Phase 1/2 Not yet recruiting
53 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting
16 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07285148 2025-12-16

A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer

Beijing Pearl Biotechnology Limited Liability Company

Phase 1/2 Not yet recruiting
253 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡